These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6824569)

  • 1. In vitro thymidine labelling of human pulmonary neoplasms.
    Kerr KM; Robertson AM; Lamb D
    Br J Cancer; 1983 Feb; 47(2):245-52. PubMed ID: 6824569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Actual growth rate and tumour cell proliferation in human pulmonary neoplasms.
    Kerr KM; Lamb D
    Br J Cancer; 1984 Sep; 50(3):343-9. PubMed ID: 6087867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of patient survival and tumour growth kinetics in human bronchogenic carcinoma.
    Kerr KM; Lamb D
    Br J Cancer; 1988 Oct; 58(4):419-22. PubMed ID: 2849973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tritiated thymidine labelling in vitro of human cancer of the breast: counting error and sampling error.
    Lambert M
    Eur J Cancer Clin Oncol; 1986 Jul; 22(7):781-5. PubMed ID: 3770036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on lung tumours. IV. Correlation between [3H]thymidine labelling of lung and liver cells and tumour formation in GRS/A and C3Hf/A male mice following administration of dimethylnitrosamine.
    de Munter HK; den Engelse L; Emmelot P
    Chem Biol Interact; 1979 Mar; 24(3):299-316. PubMed ID: 428013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The validity of the labelling index in tumour studies.
    Hamilton E; Dobbin J
    Br J Cancer; 1985 Jan; 51(1):15-21. PubMed ID: 3966970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The relationship between the doubling time of human lung tumor volume and the labelling index].
    Krutova TV; Korman DB; Aksiutina MS; Liashchenko VI; Lipchina LP
    Biull Eksp Biol Med; 1976 Jan; 81(1):59-61. PubMed ID: 1247681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3H-thymidine labelling index (TLI) as a marker of tumour growth heterogeneity: evaluation in human solid carcinomas.
    Becciolini A; Balzi M; Barbarisi M; Faraoni P; Biggeri A; Potten CS
    Cell Prolif; 1997; 30(3-4):117-26. PubMed ID: 9375024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro thymidine labelling index in primary operable breast cancer.
    Holt S; Croton R; Leinster SJ; McDicken I; Nicholson RI; Cooke TG; George WD
    Eur J Surg Oncol; 1986 Mar; 12(1):53-7. PubMed ID: 3956755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labelling patterns of carcinomas of the cervix and their precancerous stages after 3H-thymidine incorporation.
    Schubert B; Kunz J; Banaschak A
    Acta Histochem Suppl; 1983; 27():111-5. PubMed ID: 6408684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The errors of thymidine labelling in breast cancer.
    Smallwood JA; Cooper A; Taylor I
    Clin Oncol; 1983 Dec; 9(4):331-5. PubMed ID: 6661855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative autoradiographic in vitro study of the incorporation of 3H-thymidine and 3H-uridine into the DNA and RNA of solid tumours in children.
    Willnow U
    Arch Geschwulstforsch; 1980; 50(8):778-84. PubMed ID: 7224820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The labelling index of human and mouse tumours assessed by bromodeoxyuridine staining in vitro and in vivo and flow cytometry.
    Wilson GD; McNally NJ; Dunphy E; Kärcher H; Pfragner R
    Cytometry; 1985 Nov; 6(6):641-7. PubMed ID: 4064843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical cell kinetic study of human lung cancer by using monoclonal antibody to bromodeoxyuridine.
    Tada T; Kodama T; Watanabe S; Sato Y; Shimosato Y
    Jpn J Clin Oncol; 1986 Jun; 16(2):129-35. PubMed ID: 3735702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro determination of thymidine-3H labeling index in human solid tumors.
    Livingston RB; Ambus U; George SL; Freireich EJ; Hart JS
    Cancer Res; 1974 Jun; 34(6):1376-80. PubMed ID: 4363655
    [No Abstract]   [Full Text] [Related]  

  • 16. Dobule pulse labelling with 3H-thymidine: a method for calculating cell population kinetics.
    Sharav Y; Brin-Erb I; Sciaky I
    Cell Tissue Kinet; 1973 Nov; 6(6):527-4. PubMed ID: 4766936
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of methodical factors on the in vitro labeling of tissue samples with 3H-thymidine].
    Lösser R; Kunz J
    Acta Histochem Suppl; 1990; 39():93-8. PubMed ID: 2080297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell kinetic analysis of murine squamous cell carcinomas: a comparison of single versus double labelling using flow cytometry and immunohistochemistry.
    Schultz-Hector S; Begg AC; Hofland I; Kummermehr J; Sund M
    Br J Cancer; 1993 Dec; 68(6):1097-103. PubMed ID: 8260360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flash labelling of S-phase cells in short-term organ culture of normal and pathological human endometrium using bromodeoxyuridine and tritiated thymidine.
    Thornton JG; Wells M; Hume WJ
    J Pathol; 1988 Apr; 154(4):321-8. PubMed ID: 3385512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topographical analysis of proliferation ([3H]thymidine labelling index and mitotic index) as compared with tumour growth and tumour weight in xenotransplanted melanoma. Changes due to local and systemic application of azelaic acid.
    Nüssgen AI; Fritz U; Graupe K; Breitbart EW; Schmiegelow P
    Acta Derm Venereol Suppl (Stockh); 1989; 143():67-74. PubMed ID: 2773615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.